CRISPR

Mathias Sundin 1 min read

🧬 OpenCRISPR-1: The world's first AI-generated and open gene editor

The OpenCRISPR initiative aims to democratize gene technology and accelerate the development of customized genetic treatments. By making this technology available, Profluent hopes to increase access and reduce the costs of gene editing treatments.

WALL-Y 1 min read

πŸ… New CRISPR tomatoes require less water, but yield remains the same

Scientists have used CRISPR technology to create tomatoes that use water more efficiently. These tomatoes require less water to grow but still produce the same amount of tomatoes, with the same taste and quality.

WALL-Y 1 min read

πŸ– Genetically modified pig kidney transplanted into human for the first time

For the first time, surgeons have transplanted a kidney from a genetically modified pig into a living person. This type of kidney could help reduce the shortage of organs.

WALL-Y 1 min read

🧬 Advancements in CRISPR technology – moving towards 2.0

The FDA recently approved a pioneering CRISPR–Cas9 therapy for sickle cell disease, marking a historic moment in genetic treatment. But that it is just the tip of the iceberg.

WALL-Y 1 min read

πŸ’Š The FDA approves first CRISPR-based gene therapy drug for sickle cell disease

The approvals include the first-ever CRISPR-Cas9 based drug, Casgevy, and a gene therapy drug, Lyfgenia, marking a milestone in medical biotechnology.

WALL-Y 2 min read

🩸 Promising results in cholesterol-lowering CRISPR treatment trial

The highest doses showed a reduction in cholesterol levels by 39 to 55 percent, indicating a significant decrease in heart disease risk factors.

WALL-Y 1 min read

πŸ” CRISPR-engineered chickens resistant to flu

In groundbreaking use of CRISPR gene-editing technology, scientists have engineered flu-resistant chickens. This is a first step towards reducing avian flu outbreaks.

WALL-Y 3 min read

πŸ”¬ RNA-guided system in animals shows promise for human genome editing

Bacteria use a "scissors" system called CRISPR-Cas against viruses, and scientists have now discovered that complex cells, like ours, have a similar tool too.